Article
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
Gastroenterology - 1 Jun 2018
El-Sherif Omar, Jiang Z Gordon, Tapper Elliot B, Huang K C, Zhong Alex, Osinusi Anu, Charlton Michael, Manns Michael, Afdhal Nezam H, Mukamal Kenneth, McHutchison John, Brainard Diana M, Terrault Norah, Curry Michael P
Abstract excerpt
BACKGROUND & AIMS: Treatment with direct-acting antiviral (DAA) agents can reduce Model for End-Stage Liver Disease and Child-Pugh-Turcotte (CPT) scores in patients with decompensated cirrhosis caused by hepatitis C virus. However, many of these patients still die or require liver transplantation. We collected data on baseline features of patients and aimed to develop a scoring system to predict response to DAA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
